Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Barohn

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Muscle & Nerve|June 1, 1997
Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study GroupR J Hoagland, M Mendoza, C Armon, et al.
Journal of the Neurological Sciences|October 26, 2001
A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patientsC E Jackson, J Rosenfeld, D H Moore, et al.
Annals of Neurology|February 1, 1996
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study GroupR G Miller, J H Petajan, W W Bryan, et al.
Brain : a Journal of Neurology|November 18, 2009
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatmentE Matthews, D Fialho, S V Tan, et al.
Neurology|May 11, 2005
Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutationsP M Grogan, S M Tanner, K H Ørstavik, et al.
Archives of Neurology|May 18, 1999
Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristicsG I Wolfe, N S Baker, A A Amato, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|May 15, 2003
Can we eliminate placebo in ALS clinical trials?W W Bryan, R J Hoagland, J Murphy, et al.
Journal of the Neurological Sciences|December 19, 2008
Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathyC L Koski, M Baumgarten, L S Magder, et al.
Neurology|December 1, 1996
Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study GroupR G Miller, D Moore, L A Young, et al.
Neurology|August 5, 2011
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial designR G Miller, D H Moore, D A Forshew, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Muscle & Nerve|June 1, 1997
Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study GroupR J Hoagland, M Mendoza, C Armon, et al.
Journal of the Neurological Sciences|October 26, 2001
A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patientsC E Jackson, J Rosenfeld, D H Moore, et al.
Annals of Neurology|February 1, 1996
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study GroupR G Miller, J H Petajan, W W Bryan, et al.
Brain : a Journal of Neurology|November 18, 2009
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatmentE Matthews, D Fialho, S V Tan, et al.
Neurology|May 11, 2005
Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutationsP M Grogan, S M Tanner, K H Ørstavik, et al.
Archives of Neurology|May 18, 1999
Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristicsG I Wolfe, N S Baker, A A Amato, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|May 15, 2003
Can we eliminate placebo in ALS clinical trials?W W Bryan, R J Hoagland, J Murphy, et al.
Journal of the Neurological Sciences|December 19, 2008
Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathyC L Koski, M Baumgarten, L S Magder, et al.
Neurology|December 1, 1996
Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study GroupR G Miller, D Moore, L A Young, et al.
Neurology|August 5, 2011
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial designR G Miller, D H Moore, D A Forshew, et al.
Pageof 12